A new study entitled “Lung fibrotic tenascin-C up regulation is associated with other extracellular matrix proteins and induced by TGFβ1” and published in BMC Pulmonary Medicine journal suggests that the Tenascin C protein is a glycoprotein that may be relevant for fibroblastic foci activity and fibrosis…
A new study entitled “Familial and sporadic idiopathic pulmonary fibrosis: making the diagnosis from peripheral blood” published in October issue of BMC Genomics reports that the diagnosis of sporadic idiopathic pulmonary fibrosis from peripheral blood samples by identifying a functional genetic signature.The new findings could have…
A broad perspective of idiopathic pulmonary fibrosis causes were recently discussed in a wide-ranging featured lecture published on AJMC entitled “Idiopathic Pulmonary Fibrosis: Biomarkers and New Treatment Options” by expert in idiopathic pulmonary fibrosis Steven K. Huang, MD at the 2014 American College of Chest…
Drug development company Promedior Inc. recently announced the results of its Phase 1B clinical trial of PRM-15 for treating Idiopathic Pulmonary Fibrosis (IPF). Their findings show that structural and functional imaging of IPF patients correlate with data obtained from standard pulmonary tests. The new data could lead to further development of the therapy as an…
Get regular updates to your inbox.
